Related Experiment Video
Updated: Oct 16, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers
Ling Peng1, Jisheng Li2, Jie Wu3
1Department of Respiratory Disease, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Background:
SMARCA4, the essential ATPase subunit of SWI/SNF chromatin remodeling complex, regulates transcription through the control of chromatin structure and is increasingly thought to play significant roles in human cancers. This study aims to explore the potential role of SMARCA4 with a view to providing insights on pathologic mechanisms implicated here.
Methods:
The potential roles of SMARCA4 in different tumors were explored based on The Cancer Genome Atlas (TCGA), Genotype-tissue expression (GTEx), Tumor Immune Estimation Resource (TIMER), and Gene Set Enrichment Analysis (GSEA) datasets. The expression difference, mutation and phosphorylation status, survival, pathological stage, DNA methylation, tumor mutation burden (TMB), microsatellite instability (MSI), mismatch repair (MMR), tumor microenvironment (TME), and immune cell infiltration related to SMARCA4 were analyzed.
Results:
High expression levels of SMARCA4 were observed in most cancer types. SMARCA4 expression in tumor samples correlates with poor overall survival in several cancers. Lung adenocarcinoma cases with altered SMARCA4 showed a poorer prognosis. Enhanced phosphorylation levels of S613, S695, S699, and S1417 were observed in several tumors, including breast cancer. SMARCA4 correlated with tumor immunity and associated with different immune cells and genes in different cancer types. TMB, MSI, MMR, and DNA methylation correlated with SMARCA4 dysregulation in cancers. SMARCA4 expression was negatively associated with CD8+ T-cell infiltration in several tumors. Furthermore, the SWI/SNF superfamily-type complex and ATPase complex may be involved in the functional mechanisms of SMARCA4, albeit these data require further confirmation.
Conclusions:
Our study offers a comprehensive understanding of the oncogenic roles of SMARCA4 across different tumors. SMARCA4 may correlate with tumor immunity.
Insights
SMARCA4, a key component of the SWI/SNF complex, is highly expressed in many cancers and linked to poorer survival and altered tumor immunity. Its dysregulation impacts cancer progression and immune cell infiltration.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genomics
Background:
- SMARCA4 is an essential ATPase subunit of the SWI/SNF chromatin remodeling complex.
- This complex regulates gene transcription by altering chromatin structure.
- SMARCA4 is increasingly recognized for its significant roles in human cancers.
Purpose of the Study:
- To explore the potential role of SMARCA4 in various cancer types.
- To provide insights into the pathologic mechanisms involving SMARCA4 in cancer.
- To analyze the relationship between SMARCA4 and tumor immunity.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA), GTEx, TIMER, and GSEA datasets.
- Analyzed SMARCA4 expression, mutation, and phosphorylation status.
- Investigated correlations with survival, pathological stage, DNA methylation, TMB, MSI, MMR, TME, and immune cell infiltration.
Main Results:
- High SMARCA4 expression observed in most cancers, correlating with poor overall survival.
- Altered SMARCA4 in lung adenocarcinoma indicated a poorer prognosis.
- SMARCA4 dysregulation correlated with TMB, MSI, MMR, and DNA methylation, and showed associations with tumor immunity and immune cell infiltration, including negative association with CD8+ T-cell infiltration.
Conclusions:
- Provided a comprehensive understanding of SMARCA4's oncogenic roles across diverse tumors.
- Demonstrated a potential correlation between SMARCA4 and tumor immunity.
- Suggested the involvement of SWI/SNF and ATPase complexes in SMARCA4's functional mechanisms, requiring further validation.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

